{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:26:08Z","timestamp":1792031168499,"version":"4.4.0"},"reference-count":150,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["PKU2026PKULCXQ030"],"award-info":[{"award-number":["PKU2026PKULCXQ030"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32371519"],"award-info":[{"award-number":["32371519"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32350009"],"award-info":[{"award-number":["32350009"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32471515"],"award-info":[{"award-number":["32471515"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physics of Life Reviews"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.plrev.2026.06.007","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:29:18Z","timestamp":1781764158000},"page":"113-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["AI-driven cellular immunotherapy: transforming CAR-T engineering and translation"],"prefix":"10.1016","volume":"58","author":[{"given":"Ziliang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukai","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshuai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengli","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6313-6015","authenticated-orcid":false,"given":"Yiqian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plrev.2026.06.007_bib0001","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra1706169","article-title":"Chimeric antigen receptor therapy","volume":"379","author":"June","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.plrev.2026.06.007_bib0002","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1158\/2159-8290.CD-12-0548","article-title":"The basic principles of chimeric antigen receptor design","volume":"3","author":"Sadelain","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1016\/j.plrev.2026.06.007_bib0003","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/j.ymthe.2025.03.005","article-title":"From concept to cure: the evolution of CAR-T cell therapy","volume":"33","author":"Patel","year":"2025","journal-title":"Mol Ther"},{"key":"10.1016\/j.plrev.2026.06.007_bib0004","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41392-023-01680-5","article-title":"Programmable synthetic receptors: the next-generation of cell and gene therapies","volume":"9","author":"Teng","year":"2024","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.plrev.2026.06.007_bib0005","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.molmed.2012.04.009","article-title":"CAR-T cells and solid tumors: tuning T cells to challenge an inveterate foe","volume":"18","author":"Gilham","year":"2012","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.plrev.2026.06.007_bib0006","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1103849","article-title":"Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia","volume":"365","author":"Porter","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.plrev.2026.06.007_bib0007","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jcyt.2019.12.004","article-title":"The long road to the first FDA-approved gene therapy: chimeric antigen receptor T cells targeting CD19","volume":"22","author":"Braendstrup","year":"2020","journal-title":"Cytotherapy"},{"key":"10.1016\/j.plrev.2026.06.007_bib0008","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/psp4.13011","article-title":"Model-informed drug development of autologous CAR-T cell therapy: strategies to optimize CAR-T cell exposure leveraging cell kinetic\/dynamic modeling","volume":"12","author":"Mc Laughlin","year":"2023","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"key":"10.1016\/j.plrev.2026.06.007_bib0009","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1158\/2159-8290.CD-21-1683","article-title":"Next-generation CAR T-cell therapies","volume":"12","author":"Young","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.plrev.2026.06.007_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1188049","article-title":"From bench to bedside: the history and progress of CAR T cell therapy","volume":"14","author":"Mitra","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.plrev.2026.06.007_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1519671","article-title":"CAR-T cell therapy: developments, challenges and expanded applications from cancer to autoimmunity","volume":"15","author":"Kong","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.plrev.2026.06.007_bib0012","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202250039","article-title":"Four challenges to CAR T cells breaking the glass ceiling","volume":"53","author":"Bailey","year":"2023","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.plrev.2026.06.007_bib0013","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13045-025-01744-9","article-title":"Challenges and limitations of chimeric antigen receptor T-cell therapies in solid tumors: why are approvals restricted to hematologic malignancies?","volume":"18","author":"Vo","year":"2025","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.plrev.2026.06.007_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103941","article-title":"Improving CAR-T immunotherapy: overcoming the challenges of T cell exhaustion","volume":"77","author":"Gumber","year":"2022","journal-title":"eBioMedicine"},{"key":"10.1016\/j.plrev.2026.06.007_bib0015","article-title":"CAR-T cells in solid tumors: challenges and breakthroughs","volume":"6","author":"Escobar","year":"2025","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.plrev.2026.06.007_bib0016","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.7150\/ijbs.34213","article-title":"Current progress in CAR-T cell therapy for solid tumors","volume":"15","author":"Ma","year":"2019","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.plrev.2026.06.007_bib0017","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41571-023-00832-4","article-title":"CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn","volume":"21","author":"Albelda","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.plrev.2026.06.007_bib0018","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1182\/blood-2011-04-348540","article-title":"Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias","volume":"118","author":"Brentjens","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.plrev.2026.06.007_bib0019","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/mt.2010.24","article-title":"Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2","volume":"18","author":"Morgan","year":"2010","journal-title":"Mol Ther"},{"key":"10.1016\/j.plrev.2026.06.007_bib0020","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41571-022-00704-3","article-title":"Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours","volume":"20","author":"Flugel","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.plrev.2026.06.007_bib0021","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1182\/blood-2016-04-703751","article-title":"Toxicities of chimeric antigen receptor T cells: recognition and management","volume":"127","author":"Brudno","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.plrev.2026.06.007_bib0022","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.blre.2018.11.002","article-title":"Recent advances in CAR T-cell toxicity: mechanisms, manifestations and management","volume":"34","author":"Brudno","year":"2019","journal-title":"Blood Rev"},{"key":"10.1016\/j.plrev.2026.06.007_bib0023","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s13046-021-02148-6","article-title":"Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies","volume":"40","author":"Xiao","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.plrev.2026.06.007_bib0024","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41577-021-00547-6","article-title":"Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy","volume":"22","author":"Morris","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.plrev.2026.06.007_bib0025","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.omtm.2016.12.006","article-title":"Global manufacturing of CAR T cell Therapy","volume":"4","author":"Levine","year":"2017","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.plrev.2026.06.007_bib0026","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1158\/2159-8290.CD-18-0442","article-title":"Tumor antigen escape from CAR T-cell therapy","volume":"8","author":"Majzner","year":"2018","journal-title":"Cancer Discov"},{"key":"10.1016\/j.plrev.2026.06.007_bib0027","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-019-0297-y","article-title":"Engineering strategies to overcome the current roadblocks in CAR T cell therapy","volume":"17","author":"Rafiq","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.plrev.2026.06.007_bib0028","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41573-021-00189-2","article-title":"Navigating CAR-T cells through the solid-tumour microenvironment","volume":"20","author":"Hou","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.plrev.2026.06.007_bib0029","doi-asserted-by":"crossref","DOI":"10.1063\/5.0073746","article-title":"Engineering CAR T cells for enhanced efficacy and safety","volume":"6","author":"Wu","year":"2022","journal-title":"APL Bioeng"},{"key":"10.1016\/j.plrev.2026.06.007_bib0030","first-page":"95","article-title":"Armored CAR T-cells: the next chapter in T-cell cancer immunotherapy","volume":"15","author":"Hawkins","year":"2021","journal-title":"Biologics"},{"key":"10.1016\/j.plrev.2026.06.007_bib0031","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41573-019-0051-2","article-title":"Off-the-shelf\u2019 allogeneic CAR T cells: development and challenges","volume":"19","author":"Depil","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.plrev.2026.06.007_bib0032","doi-asserted-by":"crossref","first-page":"eadj6251","DOI":"10.1126\/sciadv.adj6251","article-title":"Enhancing the safety of CAR-T cell therapy: synthetic genetic switch for spatiotemporal control","volume":"10","author":"Lu","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.plrev.2026.06.007_bib0033","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.hlife.2024.06.002","article-title":"Boosting CAR-T cell therapy with CRISPR technology","volume":"2","author":"Yan","year":"2024","journal-title":"hLife"},{"key":"10.1016\/j.plrev.2026.06.007_bib0034","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41573-025-01291-5","article-title":"In vivo chimeric antigen receptor (CAR)-T cell therapy","volume":"25","author":"Bot","year":"2026","journal-title":"Nat Rev Drug Discov"},{"issue":"25","key":"10.1016\/j.plrev.2026.06.007_bib0035","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1016\/j.ymthe.2025.12.037","article-title":"Rational redesign of antigen binding domain improves in vivo efficacy of the CD22-CAR","volume":"34","author":"DeGolier","year":"2026","journal-title":"Mol Ther"},{"key":"10.1016\/j.plrev.2026.06.007_bib0036","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/s42255-024-01034-7","article-title":"Extracellular domains of CARs reprogramme T cell metabolism without antigen stimulation","volume":"6","author":"Lakhani","year":"2024","journal-title":"Nat Metab"},{"key":"10.1016\/j.plrev.2026.06.007_bib0037","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1126\/science.abq0225","article-title":"Decoding CAR T cell phenotype using combinatorial signaling motif libraries and machine learning","volume":"378","author":"Daniels","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.plrev.2026.06.007_bib0038","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ccell.2019.12.014","article-title":"THEMIS-SHP1 recruitment by 4-1BB tunes LCK-mediated priming of chimeric antigen receptor-redirected T cells","volume":"37","author":"Sun","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.plrev.2026.06.007_bib0039","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1158\/2159-8290.CD-20-1677","article-title":"Integrative bulk and single-cell profiling of premanufacture T-cell populations reveals factors mediating long-term persistence of CAR T-cell therapy","volume":"11","author":"Chen","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1016\/j.plrev.2026.06.007_bib0040","doi-asserted-by":"crossref","first-page":"eadh2605","DOI":"10.1126\/sciadv.adh2605","article-title":"TOX2 coordinates with TET2 to positively regulate central memory differentiation in human CAR T cells","volume":"9","author":"Collins","year":"2023","journal-title":"Sci Adv"},{"key":"10.1016\/j.plrev.2026.06.007_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2024.103223","article-title":"Engineering next-generation chimeric antigen receptor-T cells: recent breakthroughs and remaining challenges in design and screening of novel chimeric antigen receptor variants","volume":"90","author":"Mei","year":"2024","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.plrev.2026.06.007_bib0042","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.1016\/j.cell.2024.09.022","article-title":"Empowering biomedical discovery with AI agents","volume":"187","author":"Gao","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.plrev.2026.06.007_bib0043","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s44385-025-00021-1","article-title":"The convergence of AI and synthetic biology: the looming deluge","volume":"2","author":"Groff-Vindman","year":"2025","journal-title":"npj Biomed Innov"},{"key":"10.1016\/j.plrev.2026.06.007_bib0044","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.csbj.2024.12.030","article-title":"AI-driven multi-omics integration for multi-scale predictive modeling of genotype-environment-phenotype relationships","volume":"27","author":"Wu","year":"2025","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.plrev.2026.06.007_bib0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41746-019-0193-y","article-title":"Integrating machine learning and multiscale modeling\u2014Perspectives, challenges, and opportunities in the biological, biomedical, and behavioral sciences","volume":"2","author":"Alber","year":"2019","journal-title":"npj Digit Med"},{"key":"10.1016\/j.plrev.2026.06.007_bib0046","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/s42256-023-00744-z","article-title":"Deep learning of causal structures in high dimensions under data limitations","volume":"5","author":"Lagemann","year":"2023","journal-title":"Nat Mach Intell"},{"key":"10.1016\/j.plrev.2026.06.007_bib0047","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.plrev.2026.06.007_bib0048","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.plrev.2026.06.007_bib0049","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/s44222-025-00349-8","article-title":"AI-driven protein design","volume":"3","author":"Koh","year":"2025","journal-title":"Nat Rev Bioeng"},{"key":"10.1016\/j.plrev.2026.06.007_bib0050","article-title":"Advances in artificial intelligence (AI) models and generative algorithms represent a new paradigm for genomics research","volume":"26","author":"Lee","year":"2025","journal-title":"IJMS"},{"key":"10.1016\/j.plrev.2026.06.007_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2025.109834","article-title":"Generative AI for synthetic data across multiple medical modalities: A systematic review of recent developments and challenges","volume":"189","author":"Ibrahim","year":"2025","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.plrev.2026.06.007_bib0052","doi-asserted-by":"crossref","DOI":"10.1093\/nsr\/nwae343","article-title":"Artificial intelligence-guided strategies for next-generation biological sequence design","volume":"11","author":"Zhang","year":"2024","journal-title":"Natl Sci Rev"},{"key":"10.1016\/j.plrev.2026.06.007_bib0053","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/s41586-023-06415-8","article-title":"De novo design of protein structure and function with RFdiffusion","volume":"620","author":"Watson","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.plrev.2026.06.007_bib0054","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41586-025-09721-5","article-title":"Atomically accurate de novo design of antibodies with RFdiffusion","volume":"649","author":"Bennett","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.plrev.2026.06.007_bib0055","doi-asserted-by":"crossref","unstructured":"Al Ewaidat, O. A. & Naffaa, M. M. AI-enabled generative design of immune cells and receptors for programmable immunity. Preprint at https:\/\/doi.org\/10.20944\/preprints202511.0986.v1 (2025).","DOI":"10.20944\/preprints202511.0986.v1"},{"key":"10.1016\/j.plrev.2026.06.007_bib0056","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1158\/2643-3230.BCD-23-0240","article-title":"Advancing CAR T-cell therapies with artificial intelligence: opportunities and challenges","volume":"6","author":"Luciani","year":"2025","journal-title":"Blood Cancer Discov"},{"key":"10.1016\/j.plrev.2026.06.007_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2026.218257","article-title":"Programmable Smart CAR-T design: a new paradigm in precision immunotherapy driven by logic gates, conditional activation, allogeneic strategies, and artificial intelligence","volume":"640","author":"Wen","year":"2026","journal-title":"Cancer Lett"},{"key":"10.1016\/j.plrev.2026.06.007_bib0058","article-title":"Artificial intelligence for chimeric antigen receptor-based therapies: a comprehensive review of current applications and future perspectives","volume":"12","author":"Shahzadi","year":"2024","journal-title":"Ther Adv Vaccines Immunother"},{"key":"10.1016\/j.plrev.2026.06.007_bib0059","doi-asserted-by":"crossref","DOI":"10.3389\/frai.2025.1620572","article-title":"Artificial intelligence and machine learning in the development of vaccines and immunotherapeutics\u2014Yesterday, today, and tomorrow","volume":"8","author":"Elfatimi","year":"2025","journal-title":"Front Artif Intell"},{"key":"10.1016\/j.plrev.2026.06.007_bib0060","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1016\/j.ymthe.2020.09.015","article-title":"CAR T cell therapy for solid tumors: bright future or dark reality?","volume":"28","author":"Wagner","year":"2020","journal-title":"Mol Ther"},{"key":"10.1016\/j.plrev.2026.06.007_bib0061","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ade2886","article-title":"Splicing neoantigen discovery with SNAF reveals shared targets for cancer immunotherapy","volume":"16","author":"Li","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.plrev.2026.06.007_bib0062","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/s43018-023-00642-8","article-title":"A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo","volume":"4","author":"Giannakopoulou","year":"2023","journal-title":"Nat Cancer"},{"key":"10.1016\/j.plrev.2026.06.007_bib0063","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2024.19462","article-title":"CAR T cells and T-cell therapies for cancer: a translational science review","volume":"332","author":"Brudno","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.plrev.2026.06.007_bib0064","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41586-023-06706-0","article-title":"Targeting of intracellular oncoproteins with peptide-centric CARs","volume":"623","author":"Yarmarkovich","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.plrev.2026.06.007_bib0065","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3390\/cells14100753","article-title":"Chimeric autoantibody receptor- and\/or peptide-MHC-based CAR therapies for targeted elimination of antigen-specific B or T cells in hypersensitivity disorders such as allergies and autoimmune diseases","volume":"14","author":"Proti\u0107-Rosi\u0107","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.plrev.2026.06.007_bib0066","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010248","article-title":"MAGE-A4 pMHC-targeted CAR-T cells exploiting TCR machinery exhibit significantly improved in vivo function while retaining antigen specificity","volume":"12","author":"Liu","year":"2024","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.plrev.2026.06.007_bib0067","article-title":"Fast on-rates of chimeric antigen receptors enhance the sensitivity to peptide MHC via antigen rebinding","volume":"300","author":"Hiratsuka","year":"2024","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plrev.2026.06.007_bib0068","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.3390\/ijms27083622","article-title":"Targeting the pMHC\u2013TCR interaction: molecular strategies and therapeutic potential in autoimmunity","volume":"27","author":"Nechaeva","year":"2026","journal-title":"IJMS"},{"key":"10.1016\/j.plrev.2026.06.007_bib0069","doi-asserted-by":"crossref","unstructured":"Motmaen, A. et al. Targeting peptide\u2013MHC complexes with designed T cell receptors and antibodies. Preprint at https:\/\/doi.org\/10.1101\/2025.11.19.689381 (2025).","DOI":"10.1101\/2025.11.19.689381"},{"key":"10.1016\/j.plrev.2026.06.007_bib0070","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1126\/science.adv0422","article-title":"De novo-designed pMHC binders facilitate T cell\u2013mediated cytotoxicity toward cancer cells","volume":"389","author":"Johansen","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.plrev.2026.06.007_bib0071","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.semcancer.2023.02.007","article-title":"Artificial intelligence in cancer immunotherapy: applications in neoantigen recognition, antibody design and immunotherapy response prediction","volume":"91","author":"Li","year":"2023","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.plrev.2026.06.007_bib0072","doi-asserted-by":"crossref","first-page":"qzaf001","DOI":"10.1093\/gpbjnl\/qzaf001","article-title":"Characterization of tumor antigens from multi-omics data: computational approaches and resources","volume":"23","author":"Wang","year":"2025","journal-title":"Genom Proteom Bioinform"},{"key":"10.1016\/j.plrev.2026.06.007_bib0073","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1054231","article-title":"Artificial intelligence applied in neoantigen identification facilitates personalized cancer immunotherapy","volume":"12","author":"Cai","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.plrev.2026.06.007_bib0074","doi-asserted-by":"crossref","first-page":"eadv6445","DOI":"10.1126\/sciadv.adv6445","article-title":"Immunopeptidomics-guided discovery and characterization of neoantigens for personalized cancer immunotherapy","volume":"11","author":"Cai","year":"2025","journal-title":"Sci Adv"},{"key":"10.1016\/j.plrev.2026.06.007_bib0075","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.omtm.2018.12.009","article-title":"Engineering and design of chimeric antigen receptors","volume":"12","author":"Guedan","year":"2019","journal-title":"Mol Ther - Methods Clin Dev"},{"key":"10.1016\/j.plrev.2026.06.007_bib0076","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/s41551-024-01258-8","article-title":"Targeting overexpressed antigens in glioblastoma via CAR T cells with computationally designed high-affinity protein binders","volume":"8","author":"Xia","year":"2024","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.plrev.2026.06.007_bib0077","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41422-023-00789-0","article-title":"Tuning charge density of chimeric antigen receptor optimizes tonic signaling and CAR-T cell fitness","volume":"33","author":"Chen","year":"2023","journal-title":"Cell Res"},{"key":"10.1016\/j.plrev.2026.06.007_bib0078","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1469329","article-title":"Advancements in mammalian display technology for therapeutic antibody development and beyond: current landscape, challenges, and future prospects","volume":"15","author":"Slavny","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.plrev.2026.06.007_bib0079","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1093\/bib\/bbz095","article-title":"Computational approaches to therapeutic antibody design: established methods and emerging trends","volume":"21","author":"Norman","year":"2020","journal-title":"Br Bioinform"},{"key":"10.1016\/j.plrev.2026.06.007_bib0080","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1126\/science.ade2574","article-title":"Evolutionary-scale prediction of atomic-level protein structure with a language model","volume":"379","author":"Lin","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.plrev.2026.06.007_bib0081","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40364-025-00764-4","article-title":"Revolutionizing oncology: the role of Artificial Intelligence (AI) as an antibody design, and optimization tools","volume":"13","author":"Dewaker","year":"2025","journal-title":"Biomark Res"},{"key":"10.1016\/j.plrev.2026.06.007_bib0082","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1158\/1078-0432.CCR-13-0330","article-title":"Receptor affinity and extracellular domain modifications affect tumor recognition by ROR1-specific chimeric antigen Receptor T cells","volume":"19","author":"Hudecek","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.plrev.2026.06.007_bib0083","doi-asserted-by":"crossref","first-page":"4732","DOI":"10.1038\/s41467-023-40303-z","article-title":"Complementarity-determining region clustering may cause CAR-T cell dysfunction","volume":"14","author":"Sar\u00e9n","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.plrev.2026.06.007_bib0084","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00018-021-04089-x","article-title":"Tuning the ignition of CAR: optimizing the affinity of scFv to improve CAR-T therapy","volume":"79","author":"Duan","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.plrev.2026.06.007_bib0085","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1016\/j.ymthe.2025.07.044","article-title":"Computational structural optimization enhances IL13R\u03b12 \u2013 B7-H3 tandem CAR T cells to overcome antigen-heterogeneity-mediated tumor escape","volume":"33","author":"Meehl","year":"2025","journal-title":"Mol Ther"},{"key":"10.1016\/j.plrev.2026.06.007_bib0086","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41422-024-00936-1","article-title":"CAR-Toner: an AI-driven approach for CAR tonic signaling prediction and optimization","volume":"34","author":"Qiu","year":"2024","journal-title":"Cell Res"},{"key":"10.1016\/j.plrev.2026.06.007_bib0087","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41586-022-04654-9","article-title":"Design of protein-binding proteins from the target structure alone","volume":"605","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.plrev.2026.06.007_bib0088","doi-asserted-by":"crossref","unstructured":"Mergen, M. et al. Engineering de novo binder CAR-T cell therapies with generative AI. Preprint at https:\/\/doi.org\/10.1101\/2024.11.25.625151 (2024).","DOI":"10.1101\/2024.11.25.625151"},{"key":"10.1016\/j.plrev.2026.06.007_bib0089","doi-asserted-by":"crossref","unstructured":"Chow, A. et al. Sequence and structural determinants of efficacious de novo chimeric antigen receptors. Preprint at https:\/\/doi.org\/10.64898\/2025.12.12.694033 (2025).","DOI":"10.64898\/2025.12.12.694033"},{"key":"10.1016\/j.plrev.2026.06.007_bib0090","doi-asserted-by":"crossref","unstructured":"Kosonocky, C. W. et al. Validation and analysis of 12,000 AI-driven CAR-T designs in the Bits to binders competition. Preprint at https:\/\/doi.org\/10.64898\/2026.03.03.709355 (2026).","DOI":"10.64898\/2026.03.03.709355"},{"key":"10.1016\/j.plrev.2026.06.007_bib0091","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12929-025-01190-2","article-title":"Technological advancements in antibody-based therapeutics for treatment of diseases","volume":"32","author":"Lu","year":"2025","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.plrev.2026.06.007_bib0092","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/1804038","article-title":"The potential of single-chain variable fragment antibody: role in future therapeutic and diagnostic biologics","volume":"2024","author":"Gezehagn Kussia","year":"2024","journal-title":"J Immunol Res"},{"key":"10.1016\/j.plrev.2026.06.007_bib0093","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.str.2025.08.007","article-title":"Code to complex: AI-driven de novo binder design","volume":"33","author":"Fox","year":"2025","journal-title":"Structure"},{"key":"10.1016\/j.plrev.2026.06.007_bib0094","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1158\/2326-6066.CIR-24-1347","article-title":"CAR binders affect CAR T-cell tonic signaling, durability, and sensitivity to target","volume":"13","author":"Shukla","year":"2025","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.plrev.2026.06.007_bib0095","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010658","article-title":"Expanding the CAR toolbox with high throughput screening strategies for CAR domain exploration: a comprehensive review","volume":"13","author":"Roex","year":"2025","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.plrev.2026.06.007_bib0096","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jcyt.2024.02.024","article-title":"Alternative target recognition elements for chimeric antigen receptor (CAR) T cells: beyond standard antibody fragments","volume":"26","author":"Nix","year":"2024","journal-title":"Cytotherapy"},{"key":"10.1016\/j.plrev.2026.06.007_bib0097","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood-2013-03-490565","article-title":"Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma","volume":"122","author":"Linette","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.plrev.2026.06.007_bib0098","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1158\/1535-7163.MCT-21-0115","article-title":"T-cell receptor mimic antibodies for cancer immunotherapy","volume":"20","author":"Duan","year":"2021","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.plrev.2026.06.007_bib0099","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1126\/science.adv3813","article-title":"De novo design and structure of a peptide\u2013centric TCR mimic binding module","volume":"389","author":"Householder","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.plrev.2026.06.007_bib0100","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.adv0185","article-title":"Design of high-specificity binders for peptide\u2013MHC-I complexes","volume":"389","author":"Liu","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.plrev.2026.06.007_bib0101","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1126\/science.adz6423","article-title":"Beyond the native repertoire","volume":"389","author":"Hickok","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.plrev.2026.06.007_bib0102","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/s42256-025-01096-6","article-title":"Conditional generation of real antigen-specific T cell receptor sequences","volume":"7","author":"Karthikeyan","year":"2025","journal-title":"Nat Mach Intell"},{"key":"10.1016\/j.plrev.2026.06.007_bib0103","unstructured":"Ma, J., Li, H., Hu, Y.-F. & Huang, J.-D. Physicochemically informed dual-conditioned generative model of T-cell receptor variable regions for cellular therapy. Preprint at https:\/\/doi.org\/10.48550\/ARXIV.2510.05747 (2025)."},{"key":"10.1016\/j.plrev.2026.06.007_bib0104","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nm.3838","article-title":"4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors","volume":"21","author":"Long","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.plrev.2026.06.007_bib0105","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.it.2015.06.004","article-title":"Engineering CAR-T cells: design concepts","volume":"36","author":"Srivastava","year":"2015","journal-title":"Trends Immunol"},{"key":"10.1016\/j.plrev.2026.06.007_bib0106","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1016\/j.immuni.2024.11.005","article-title":"Phase separation of chimeric antigen receptor promotes immunological synapse maturation and persistent cytotoxicity","volume":"57","author":"Xu","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.plrev.2026.06.007_bib0107","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/imr.13236","article-title":"Harnessing the power of artificial intelligence to advance cell therapy","volume":"320","author":"Capponi","year":"2023","journal-title":"Immunol Rev"},{"key":"10.1016\/j.plrev.2026.06.007_bib0108","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-68272-5","article-title":"AI-guided CAR designs and targeted pathway modulation to enhance multi-antigen CAR T cell durability and overcome antigen escape","volume":"17","author":"Ansari","year":"2026","journal-title":"Nat Commun"},{"key":"10.1016\/j.plrev.2026.06.007_bib0109","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cels.2020.08.002","article-title":"Discriminatory power of combinatorial antigen recognition in cancer T cell therapies","volume":"11","author":"Dannenfelser","year":"2020","journal-title":"Cell Syst"},{"key":"10.1016\/j.plrev.2026.06.007_bib0110","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41568-022-00505-x","article-title":"Rethinking cancer targeting strategies in the era of smart cell therapeutics","volume":"22","author":"Allen","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.plrev.2026.06.007_bib0111","doi-asserted-by":"crossref","unstructured":"Tastan, C. & Aydin, B. Artificial Intelligence\u2013Guided design of CAR-T cells for solid tumors through CD-antigen prioritization, safety-by-design architectures, and constrained large language model reasoning. bioRxiv 2026.01.10.698833 (2026) doi:10.64898\/2026.01.10.698833.","DOI":"10.64898\/2026.01.10.698833"},{"key":"10.1016\/j.plrev.2026.06.007_bib0112","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.904497","article-title":"CAR T-cell therapy predictive response markers in diffuse large B-cell lymphoma and therapeutic options after CART19 failure","volume":"13","author":"Caballero","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.plrev.2026.06.007_bib0113","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1378944","article-title":"Biomarkers for prediction of CAR T therapy outcomes: current and future perspectives","volume":"15","author":"Levstek","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.plrev.2026.06.007_bib0114","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41591-025-03532-x","article-title":"An inflammatory biomarker signature of response to CAR-T cell therapy in non-hodgkin lymphoma","volume":"31","author":"Raj","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.plrev.2026.06.007_bib0115","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1200\/JCO.2025.43.16_suppl.2536","article-title":"Artificial intelligence (XGBoost) in predicting outcomes among CAR-T therapy patients: the impact of malnutrition and comorbidities using the National Inpatient Sample (2020-2022)","volume":"43","author":"Ren","year":"2025","journal-title":"JCO"},{"key":"10.1016\/j.plrev.2026.06.007_bib0116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0282573","article-title":"Prediction of lymphoma response to CAR T cells by deep learning-based image analysis","volume":"18","author":"Tong","year":"2023","journal-title":"PLoS ONE"},{"key":"10.1016\/j.plrev.2026.06.007_bib0117","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1182\/blood-2025-2585","article-title":"Deep learning-based image analysis of pretreatment FDG-PET\/CT predicts CAR-T cell treatment outcome at month-12 for patients with relapsed\/refractory large B-cell lymphomas","volume":"146","author":"Schuster","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.plrev.2026.06.007_bib0118","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1692892","article-title":"Machine learning-based predictive model for high- grade cytokine release syndrome in chimeric antigen receptor T-cell therapy","volume":"16","author":"Yu","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.plrev.2026.06.007_bib0119","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2023.104367","article-title":"Meta-analysis informed machine learning: supporting cytokine storm detection during CAR-T cell Therapy","volume":"142","author":"Bogatu","year":"2023","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.plrev.2026.06.007_bib0120","unstructured":"Ni, Y., Zhu, L. & Li, S. Bio AI Agent: A multi-agent artificial intelligence system for autonomous CAR-T cell therapy development with integrated target discovery, toxicity prediction, and rational molecular design. Preprint at https:\/\/doi.org\/10.48550\/ARXIV.2511.08649 (2025)."},{"key":"10.1016\/j.plrev.2026.06.007_bib0121","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/cimb47050321","article-title":"The potential use of digital twin technology for advancing CAR-T cell therapy","volume":"47","author":"Aghamiri","year":"2025","journal-title":"CIMB"},{"key":"10.1016\/j.plrev.2026.06.007_bib0122","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2026.105171","article-title":"Digital twins in oncology: from predictive modelling to personalised treatment strategies","volume":"220","author":"Olawade","year":"2026","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"10.1016\/j.plrev.2026.06.007_bib0123","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/s41568-025-00850-7","article-title":"Application of digital twins for personalized oncology","volume":"25","author":"Asghar","year":"2025","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.plrev.2026.06.007_bib0124","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.3390\/jcm14103574","article-title":"Exploring the potential of digital twins in cancer treatment: a narrative review of reviews","volume":"14","author":"Giansanti","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.plrev.2026.06.007_bib0125","doi-asserted-by":"crossref","first-page":"bbaf237","DOI":"10.1093\/bib\/bbaf237","article-title":"Advances and critical aspects in cancer treatment development using digital twins","volume":"26","author":"Bouriga","year":"2025","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.plrev.2026.06.007_bib0126","article-title":"Digital twins: a new paradigm in oncology in the era of big data","volume":"5","author":"Mollica","year":"2024","journal-title":"ESMO Real World Data Digit Oncol"},{"issue":"26","key":"10.1016\/j.plrev.2026.06.007_bib0127","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1016\/j.cell.2026.02.009","article-title":"Bringing the genetically minimal cell to life on a computer in 4D","volume":"189","author":"Thornburg","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.plrev.2026.06.007_bib0128","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/s41587-023-01687-x","article-title":"Deconvolution of clinical variance in CAR-T cell pharmacology and response","volume":"41","author":"Kirouac","year":"2023","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.plrev.2026.06.007_bib0129","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2522634122","article-title":"Physiologically based pharmacokinetic model for CAR-T cell delivery and efficacy in solid tumors","volume":"122","author":"Hadjigeorgiou","year":"2025","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.plrev.2026.06.007_bib0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41540-025-00642-7","article-title":"Mathematical modeling of combinatorial antigen targeting with multiple CAR T-cell products for glioblastoma treatment","volume":"12","author":"Li","year":"2026","journal-title":"npj Syst Biol Appl"},{"key":"10.1016\/j.plrev.2026.06.007_bib0131","doi-asserted-by":"crossref","DOI":"10.1038\/mto.2016.15","article-title":"Clinical manufacturing of CAR T cells: foundation of a promising therapy","volume":"3","author":"Wang","year":"2016","journal-title":"Mol Ther - Oncolytics"},{"key":"10.1016\/j.plrev.2026.06.007_bib0132","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1053\/j.seminhematol.2020.07.005","article-title":"Improving CAR T cell therapy by optimizing critical quality attributes","volume":"57","author":"Reddy","year":"2020","journal-title":"Semin Hematol"},{"key":"10.1016\/j.plrev.2026.06.007_bib0133","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.876339","article-title":"Impact of manufacturing procedures on CAR T cell functionality","volume":"13","author":"Watanabe","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.plrev.2026.06.007_bib0134","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20230903","article-title":"CAR-T cell manufacturing: major process parameters and next-generation strategies","volume":"221","author":"Ayala Ceja","year":"2024","journal-title":"J Exp Med"},{"key":"10.1016\/j.plrev.2026.06.007_bib0135","article-title":"Toward rapid, widely available autologous CAR-T cell therapy - artificial intelligence and automation enabling the Smart Manufacturing Hospital","volume":"9","author":"Hort","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.plrev.2026.06.007_bib0136","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.jcyt.2024.03.042","article-title":"Machine learning enables high density T-cell expansion with lower costs while maintaining product quality","volume":"26","author":"Safford","year":"2024","journal-title":"Cytotherapy"},{"key":"10.1016\/j.plrev.2026.06.007_bib0137","doi-asserted-by":"crossref","DOI":"10.1002\/btpr.70045","article-title":"A digital shadow of CAR T cell expansion in a perfusion bioreactor: informing optimal harvest times for autologous cell therapy","volume":"41","author":"Egan","year":"2025","journal-title":"Biotechnol Prog"},{"key":"10.1016\/j.plrev.2026.06.007_bib0138","doi-asserted-by":"crossref","DOI":"10.3389\/fmmed.2023.1250508","article-title":"Elaborating the potential of Artificial intelligence in automated CAR-T cell manufacturing","volume":"3","author":"B\u00e4ckel","year":"2023","journal-title":"Front Mol Med"},{"key":"10.1016\/j.plrev.2026.06.007_bib0139","article-title":"An analysis of monitoring solutions for CAR T cell production","volume":"12","author":"Shoshi","year":"2025","journal-title":"Heal Technol Lett"},{"key":"10.1016\/j.plrev.2026.06.007_bib0140","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.procir.2024.08.027","article-title":"Reinforcement Learning based resource management for CAR T-cell therapies","volume":"125","author":"Szentp\u00e9teri","year":"2024","journal-title":"Procedia CIRP"},{"key":"10.1016\/j.plrev.2026.06.007_bib0141","doi-asserted-by":"crossref","first-page":"eadk2298","DOI":"10.1126\/sciadv.adk2298","article-title":"Machine learning predictions of T cell antigen specificity from intracellular calcium dynamics","volume":"10","author":"This","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.plrev.2026.06.007_bib0142","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1009883","article-title":"In vitro machine learning-based CAR T immunological synapse quality measurements correlate with patient clinical outcomes","volume":"18","author":"Naghizadeh","year":"2022","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.plrev.2026.06.007_bib0143","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.jcyt.2023.08.011","article-title":"Real-time semantic segmentation and anomaly detection of functional images for cell therapy manufacturing","volume":"25","author":"Chen","year":"2023","journal-title":"Cytotherapy"},{"key":"10.1016\/j.plrev.2026.06.007_bib0144","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jcyt.2024.03.011","article-title":"Interfacing data science with cell therapy manufacturing: where we are and where we need to be","volume":"26","author":"Wang","year":"2024","journal-title":"Cytotherapy"},{"key":"10.1016\/j.plrev.2026.06.007_bib0145","doi-asserted-by":"crossref","unstructured":"Mao, T. et al. CART-GPT: a T cell-informed AI linguistic framework for interpreting neurotoxicity and therapeutic outcomes in CAR-T therapy. Preprint at https:\/\/doi.org\/10.1101\/2025.08.08.669387 (2025).","DOI":"10.1101\/2025.08.08.669387"},{"key":"10.1016\/j.plrev.2026.06.007_bib0146","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2024.104646","article-title":"A survey of recent methods for addressing AI fairness and bias in biomedicine","volume":"154","author":"Yang","year":"2024","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.plrev.2026.06.007_bib0147","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10628","article-title":"An AI-assisted integrated, scalable, single-cell phenomic-transcriptomic platform to elucidate intratumor heterogeneity against immune response","volume":"9","author":"Tostado","year":"2024","journal-title":"Bioeng Transl Med"},{"key":"10.1016\/j.plrev.2026.06.007_bib0148","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/s41586-025-09507-9","article-title":"Systematic discovery of CRISPR-boosted CAR T cell immunotherapies","volume":"646","author":"Datlinger","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.plrev.2026.06.007_bib0149","first-page":"726","article-title":"Three-tier framework for high-throughput biofabrication: integrating 3D bioprinting, assistive platforms, and translational opportunities","volume":"57","author":"Singh","year":"2026","journal-title":"Bioact Mater"},{"key":"10.1016\/j.plrev.2026.06.007_bib0150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ddtec.2020.07.001","article-title":"The good, the bad, and the ugly in chemical and biological data for machine learning","volume":"32-33","author":"Rodrigues","year":"2019","journal-title":"Drug Discov Today: Technol"}],"container-title":["Physics of Life Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1571064526000503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1571064526000503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T21:11:17Z","timestamp":1788556277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1571064526000503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":150,"alternative-id":["S1571064526000503"],"URL":"https:\/\/doi.org\/10.1016\/j.plrev.2026.06.007","relation":{},"ISSN":["1571-0645"],"issn-type":[{"value":"1571-0645","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AI-driven cellular immunotherapy: transforming CAR-T engineering and translation","name":"articletitle","label":"Article Title"},{"value":"Physics of Life Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plrev.2026.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}